[1] 胡红.咳嗽变异性哮喘的诊断及治疗进展[J].解放军医学杂志,2014,39(5):361~364. [2] 李娜,卓宋明,荀安营,等.布地奈德/福莫特罗干粉剂联合孟鲁司特治疗咳嗽变异性哮喘的效果[J].广东医学,2014,28(10):1605~1607. [3] 于兴梅,郝创利.儿童咳嗽变异性哮喘患者气道高反应的动态观察[J].中国实用内科杂志,2014,94(1):42~43. [4] 朱海艳,于兴梅,郝创利,等.呼出气一氧化氮测定对儿童咳嗽变异性哮喘的诊断价值[J].中华结核和呼吸杂志,2015,38(5):352~355. [5] Saito N, Itoga M, Tamaki M, et al. Cough variant asthma patients are more depressed and anxious than classic asthma patients[J].Journal of Psychosomatic Research, 2015, 79(1):18~26. [6] Huiping M A, Wei L I, Liu X. Matrix metalloproteinase 9 is involved in airway inflammation in cough variant asthma[J].Experimental & Therapeutic Medicine, 2014,8(4):1197~1200. [7] Tajiri T, Niimi A, Matsumoto H, et al. Prevalence and Clinical Relevance of Allergic Rhinitis in Patients with Classic Asthma and Cough Variant Asthma[J].Respiration; international review of thoracic diseases, 2014, 87(3):211~218. [8] Dicpinigaitis P V. Letter to the Editor on Saito et al. "Cough variant asthma patients are more depressed and anxious than classic asthma patients[J].Journal of Psychosomatic Research, 2015, 79(1):88~89. [9] 徐敏洁,宋丽萍.布地奈德治疗中重度支气管哮喘急性发作患儿的效果及对肺功能的影响[J].中国医院药学杂志,2014,34(7):565~568. [10] 许银姬,周明娟,梁桂兴,等.咳嗽变异性哮喘患者规范治疗2年的随访研究[J].广东医学,2016,37(14):2104~2107. [11] 吴奎,王彦,陈章,等.糖皮质激素吸入对咳嗽变异性哮喘患者呼出气NO水平的影响[J].重庆医学,2015,34(8):1041~1043. [12] 刘美娟,王蓬伟,林松娟,等.苏黄止咳胶囊联合布地柰德吸入治疗咳嗽变异性哮喘临床研究[J].中成药,2014,36(6):1161~1163. [13] 吴莉菁,肖国军.孟鲁司特钠片联合布地奈德混悬液治疗咳嗽变异性哮喘患儿的临床研究[J].中国临床药理学杂志,2016,32(22):2032~2035 [14] 魏延,李东升,刘建军,等.孟鲁司特钠联合布地奈德治疗儿童咳嗽变异性哮喘疗效和安全性的Meta分析[J].中国当代儿科杂志,2016,18(11):1100~1105. [15] 彭秋凤,张秀义,桑晓一,等.不同剂量布地奈德吸入治疗咳嗽变异性哮喘对比观察[J].山东医药,2014,54(7):74~76.
2017, Vol. 23 
冀公网安备13080202000677号